Joshi Priscilla C, Jahanvi Vandana, Mahajan Mangal S, Patil Nivedita C Ghule, Moradiya Priyankkumar G, Pawar Shivani N
Department of Radiodiagnosis and Imaging, Bharati Vidyapeeth Deemed to be University Medical College and Hospital, Pune, Maharashtra, India.
Indian J Radiol Imaging. 2022 Jan 10;31(4):888-892. doi: 10.1055/s-0041-1741052. eCollection 2021 Oct.
Computerized tomography (CT) is an invaluable imaging investigation for evaluating COVID-19 disease. CT detects early changes of COVID-19 pneumonia and predicts the disease prognosis based on a semiquantitative 25-point CT severity score (CT-SS). India launched its vaccination drive in January 2021 with two different vaccines being approved by the government. These vaccines are believed to prevent the disease itself, in majority of the cases and at least decrease disease severity, in the rest. This study aims to evaluate the CT-SS in vaccinated and non-vaccinated subjects who have been diagnosed with COVID-pneumonia or are COVID suspects. A total of 3,235 patients with typical COVID-19 related imaging findings on HRCT thorax were included in the study. These subjects were divided into three age categories, 18-44, 45-59 and ≥60 years. The CT severity scores were allotted by experienced radiologists. Medians of the scores in different age groups were compared amongst vaccinated and non-vaccinated individuals using the Kruskal-Wallis H test. A value < 0.05 was considered significant. All results were shown with 95% confidence interval. The difference in the medians amongst the vaccinated and non-vaccinated groups was significant, -values being < 0.001 in all age categories. The mean CT-SS was less in vaccinated subjects and the difference in median CT-SS amongst vaccinated and non-vaccinated individuals was statistically significant, thus sending an important message that it is mandatory for the population at large to get vaccinated to reduce infection rate/disease severity.
计算机断层扫描(CT)是评估新型冠状病毒肺炎(COVID-19)疾病的一项重要影像学检查。CT可检测出COVID-19肺炎的早期变化,并根据半定量的25分CT严重程度评分(CT-SS)预测疾病预后。印度于2021年1月启动了疫苗接种计划,政府批准了两种不同的疫苗。这些疫苗被认为在大多数情况下可预防疾病本身,在其余情况下至少可降低疾病严重程度。 本研究旨在评估已被诊断为COVID-肺炎或疑似COVID的接种疫苗和未接种疫苗的受试者的CT-SS。 共有3235例在胸部高分辨率CT(HRCT)上有典型COVID-19相关影像学表现的患者纳入研究。这些受试者分为三个年龄组,18 - 44岁、45 - 59岁和≥60岁。CT严重程度评分由经验丰富的放射科医生分配。使用Kruskal-Wallis H检验比较接种疫苗和未接种疫苗个体在不同年龄组中的评分中位数。P值<0.05被认为具有统计学意义。所有结果均以95%置信区间表示。 接种疫苗组和未接种疫苗组之间的中位数差异具有统计学意义,所有年龄组的P值均<0.001。 接种疫苗的受试者的平均CT-SS较低,接种疫苗和未接种疫苗个体之间的CT-SS中位数差异具有统计学意义,因此传递了一个重要信息,即广大人群必须接种疫苗以降低感染率/疾病严重程度。